Flow cytometric study of in vitro neutrophil activation by biomaterials.
Neutrophil activation for adherent and nonadherent cells, as measured by flow cytometry, was not strongly dependent on material surface chemistry. We had hypothesized that material-induced neutrophil activation was an important parameter associated with material failure. All materials tested [cellophane, an acrylonitrile copolymer (AN69), Pellethane, nylon, polyethylene terephthalate, low density polyethylene, and polydimethylsiloxane] activated isolated human neutrophils, which were resuspended in plasma or serum, to similar extents based on L-selectin shedding, CD11b upregulation, and stimulation of the oxidative burst after 30-min exposure. Inhibition of complement activation by sCR1 unexpectedly had little effect if any on nonadherent neutrophils. However, neutrophil adhesion, but not the level of activation of the adherent cells, was strongly dependent on complement activation. Pretreatment with albumin did not inhibit adhesion or reduce neutrophil activation, but plasma pretreatment resulted in increased activation for nonadherent and adherent cells. More adhesion and a higher level of activation of adherent cells was observed following pretreatment with fibrinogen, a ligand of CD11b. Taken together these results suggest that upon contact with a material, neutrophil activation may occur though mechanisms that are not mediated by complement. For example, the presence of plasma proteins such as fibrinogen at the interface may trigger activation and the release of other activating agents. Although the material differences are small, the extent of activation may be significant and warrant further study of the mechanism and consequences of that activation.
Department of Chemical Engineering and Applied Chemistry, Centre for Biomaterials, University of Toronto, Ontario, M5S 3E5, Canada.
M B
MB
Gorbet
E L
EL
Yeo
M V
MV
Sefton
D000180:Acrylic Resins / Q000494:pharmacology / Q000633:toxicity; D000181:Acrylonitrile / Q000031:analogs & derivatives / Q000494:pharmacology / Q000633:toxicity; D000327:Adsorption; D001672:Biocompatible Materials / Q000494:pharmacology* / Q000633:toxicity; D002448:Cell Adhesion / Q000187:drug effects; D002476:Cellophane / Q000494:pharmacology / Q000633:toxicity; D020099:Coated Materials, Biocompatible / Q000494:pharmacology / Q000633:toxicity; D003167:Complement Activation; D004129:Dimethylpolysiloxanes / Q000494:pharmacology / Q000633:toxicity; D005340:Fibrinogen; D005434:Flow Cytometry; D005549:Foreign-Body Reaction / Q000209:etiology*; D006801:Humans; D016177:Macrophage-1 Antigen / Q000502:physiology; D009504:Neutrophils / Q000187:drug effects* / Q000502:physiology; D009757:Nylons / Q000494:pharmacology / Q000633:toxicity; D010949:Plasma; D020959:Polyethylene / Q000494:pharmacology / Q000633:toxicity; D011093:Polyethylene Terephthalates / Q000494:pharmacology / Q000633:toxicity; D011140:Polyurethanes / Q000494:pharmacology / Q000633:toxicity; D016897:Respiratory Burst / Q000187:drug effects*; D012710:Serum Albumin, Bovine / Q000737:chemistry; D012828:Silicones / Q000494:pharmacology / Q000633:toxicity
D000180:Acrylic Resins; D001672:Biocompatible Materials; D020099:Coated Materials, Biocompatible; D004129:Dimethylpolysiloxanes; D016177:Macrophage-1 Antigen; D009757:Nylons; D011093:Polyethylene Terephthalates; D011140:Polyurethanes; D012828:Silicones; D012710:Serum Albumin, Bovine; C016892:AN-69; C013830:baysilon; D005340:Fibrinogen; D020959:Polyethylene; D002476:Cellophane; D000181:Acrylonitrile